Your browser doesn't support javascript.
loading
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
Loomba, Rohit; Mohseni, Rizwana; Lucas, K Jean; Gutierrez, Julio A; Perry, Robert G; Trotter, James F; Rahimi, Robert S; Harrison, Stephen A; Ajmera, Veeral; Wayne, Jeffrey D; O'Farrell, Marie; McCulloch, William; Grimmer, Katharine; Rinella, Mary; Wai-Sun Wong, Vincent; Ratziu, Vlad; Gores, Gregory J; Neuschwander-Tetri, Brent A; Kemble, George.
Afiliación
  • Loomba R; Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California at San Diego, La Jolla, California. Electronic address: roloomba@ucsd.edu.
  • Mohseni R; Catalina Research Institute, Montclair, California.
  • Lucas KJ; Lucas Research, Morehead City, North Carolina.
  • Gutierrez JA; Prosciento, Chula Vista, California.
  • Perry RG; Panax Clinical Research, Miami Lakes, Florida.
  • Trotter JF; Baylor University Medical Center, Texas Digestive Disease Consultants, Dallas, Texas.
  • Rahimi RS; Baylor University Medical Center, Texas Digestive Disease Consultants, Dallas, Texas.
  • Harrison SA; Pinnacle Clinical Research, San Antonio, Texas.
  • Ajmera V; Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California at San Diego, La Jolla, California.
  • Wayne JD; Clinical Trials Research, Lincoln, California.
  • O'Farrell M; Sagimet Biosciences Inc., San Mateo, California.
  • McCulloch W; Sagimet Biosciences Inc., San Mateo, California.
  • Grimmer K; Sagimet Biosciences Inc., San Mateo, California.
  • Rinella M; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Wai-Sun Wong V; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
  • Ratziu V; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtriére, Institute for Cardiometabolism and Nutrition, Paris, France.
  • Gores GJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Neuschwander-Tetri BA; Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St Louis, Missouri.
  • Kemble G; Sagimet Biosciences Inc., San Mateo, California.
Gastroenterology ; 161(5): 1475-1486, 2021 11.
Article en En | MEDLINE | ID: mdl-34310978
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Triazoles / Inhibidores Enzimáticos / Lipogénesis / Acido Graso Sintasa Tipo I / Enfermedad del Hígado Graso no Alcohólico / Hígado / Cirrosis Hepática / Nitrilos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gastroenterology Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Triazoles / Inhibidores Enzimáticos / Lipogénesis / Acido Graso Sintasa Tipo I / Enfermedad del Hígado Graso no Alcohólico / Hígado / Cirrosis Hepática / Nitrilos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gastroenterology Año: 2021 Tipo del documento: Article